Načítá se...
Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
PURPOSE: To evaluate the effects of intravitreal bevacizumab (IVB) injection on chronic central serous chorioretinopathy (CSC). METHODS: In this prospective interventional case series, a total of 22 eyes of 22 patients, diagnosed with unresolved CSC for three months or longer, received 1.25 mg IVB i...
Uloženo v:
| Vydáno v: | J Curr Ophthalmol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6896463/ https://ncbi.nlm.nih.gov/pubmed/31844791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joco.2019.06.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|